About BioEnTech
BioEnTech is an Energy & Utilities company based in Lyon (France) founded in 2013, and was acquired by SUEZ in October 2022. Bioprocessing monitoring solutions are provided for biogas plants. BioEnTech has raised $7.29 million across 2 funding rounds from investors including Crédit Agricole, SUEZ and Bpifrance. BioEnTech offers products and services including MeMo, IR-SCAN, and SNAC. Its focus areas include Energy Tech, Renewable Energy Tech, Bioenergy and Software Solutions.
Company details
BioEnTech was founded in 2013 and is located in Lyon, France. Operations focus on the bioprocessing sector, where monitoring solutions for biogas plants are developed. The MeMo-pro system centralizes collected data to estimate key process variables and diagnose reactor physiological states in real-time. Disturbances are detected quickly, and corrective actions are proposed to stabilize and optimize processes.
- Headquarters Lyon, France
- Stage Acquired
- SectorsEnergy & Utilities
- Email••••••••
- Phone•••• ••••
- Website bioentech.eu
- Social LinkedIn
- Acquired by SUEZ (Oct 2022)
- Total Equity Funding$7.29M (USD)
in 2 rounds
- Latest Funding Round$6.34M (USD), Series A
Feb 2017
- InvestorsCrédit Agricole
& 5 more
- Acquired bySUEZ
(Oct 2022)
Products & Services of BioEnTech
BioEnTech offers a comprehensive portfolio of products and services, including MeMo, IR-SCAN, and SNAC.
Solution for monitoring and decision support in methanizers.
Evaluates potential yield of organic materials for optimization.
In-situ sensor for simplified methanizer tracking and management.
Funding Insights of BioEnTech
BioEnTech has successfully raised a total of $7.29M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.34 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.29M
- Total Rounds 2
- Last Round Series A — $6.34M
- First Round $949,023
(Dec 2016)
- Investors Count 5
All 2 funding rounds of BioEnTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $6.34M | Series A | – | SOFILARO, IRDI Soridec Gestion | – |
| Dec 2016 | $949,023 | Seed | – | Bpifrance |
6 investors in total: 6 institutional.
Investors in BioEnTech
BioEnTech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, SUEZ and Bpifrance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regional capital investment services are provided by SOFILARO CALEN. | sofilaro.fr | France | ||
| irdisoridec.fr | ||||
Crédit Agricole is recognized as a leading banking institution in France. | 1894 | credit-agricole.com | Montrouge, France | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France | |
| ca-creation.ca | ||||
Provider of solutions for water and waste treatment | 1869 | suez.com | Paris, France |
Investor details for BioEnTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioEnTech
4 dated milestones of BioEnTech across 9 years, from founding to its latest funding, stage changes and deals.
- Founded BioEnTech is founded.
- Funding First funding round of $949K.
- Funding Latest funding round, Series A, of $6.3M.
- Exit Acquired by SUEZ.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioentech
Complete news archive for BioEnTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioEnTech
BioEnTech was founded in 2013 and raised its 1st funding round 3 years after it was founded.
BioEnTech is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
BioEnTech is a funded company, having raised a total of $7.29M across 2 funding rounds to date. The company's 1st funding round was a Seed of $949.02K, raised on Dec 2016.
BioEnTech was founded in 2013 and is located in Lyon, France. Operations focus on the bioprocessing sector, where monitoring solutions for biogas plants are developed. The MeMo-pro system centralizes collected data to estimate key process variables and diagnose reactor physiological states in real-time. Disturbances are detected quickly, and corrective actions are proposed to stabilize and optimize processes.
BioEnTech offers MeMo, IR-SCAN, and SNAC.
BioEnTech has 6 investors. Key investors include Crédit Agricole, SUEZ, Bpifrance, SOFILARO CALEN, and IRDI Soridec Gestion.
Yes. BioEnTech was acquired by SUEZ in October 2022.